1. Quinn CE, Healy J, Lebastchi AH, Brown TC, Stein JE, Prasad ML, et al. Modern experience with aggressive parathyroid tumors in a high-volume New England referral center. J Am Coll Surg. 2015;220:1054–62.
2. Bondeson L, Grimelius L, DeLellis RA, Lloyd R, Åkerström G, Larsson C, et al. Parathyroid carcinoma and parathyroid adenoma. In: DeLellis RA, Lloyd RV, Heitz PU, et al., editors. Pathology and genetics of tumours of endocrine organs. Lyon: International Agency for Research on Cancer Press, 2004. p. 124–32.
3. DeLellis RA, Arnold A, Bilezikian JP, Eng C, Larsson C, Lloyd RV, et al. Tumours of the parathyroid glands. In: Lloyd RV, Osamura RY, Klöppel G et al., editors. WHO classification of tumours of endocrine organs. Fourth edition. Lyon: International Agency for Research on Cancer, 2017. p. 146–58.
4. Carpten JD, Robbins CM, Villablanca A, Forsberg L, Presciuttini S, Bailey-Wilson J, et al. HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nat Genet. 2002;32:676–80.
5. Shattuck TM, Välimäki S, Obara T, Gaz RD, Clark OH, Shoback D, et al. Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. N Engl J Med. 2003;349:1722–9.